Retinal implant halts vision loss from macular degeneration

April 04, 2018

A bioengineered retinal implant is safe for use in humans and may be effective in treating vision loss caused by a type of macular degeneration, a progressive blinding disease where no therapeutic options currently exist for advanced stages of the condition. The findings from the phase 1/2a clinical trial (which encompasses two phases of analysis) may pave the way to a potential new therapy for advanced non-neovascular age-related macular degeneration (or NNAMD, also known as "Dry" AMD). NNAMD is associated with loss of the retinal pigment epithelium (RPE), a membrane that nourishes and protects retinal visual cells in the eye. Here, Amir Kashani and colleagues examined the safety and efficacy of a bioengineered retinal implant, which they previously developed and tested in rodents. Their implant is composed of human embryonic stem cells that rest on a material and form a membrane, mimicking the RPE. The authors inserted the implant into the eyes of four subjects with advanced NNAMD and monitored their vision over the course of four months to a year. The implant was well tolerated by all four subjects, who maintained their vision throughout the duration of the study (one even demonstrated an observable improvement in visual acuity). Furthermore, post-operative images revealed stem cells in the implants successfully integrated with the subjects' retinal tissue, and their retinas exhibited anatomical changes consistent with reappearance of the RPE. As a next step, the researchers plan to conduct larger prospective studies to further assess the efficacy of the implant for treating NNAMD in humans.
-end-


American Association for the Advancement of Science

Related Macular Degeneration Articles from Brightsurf:

Levodopa may improve vision in patients with macular degeneration
Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision.

Combating drug resistance in age-related macular degeneration
An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for age-related macular degeneration,

Study finds unexpected suspect in age-related macular degeneration
Scientists have identified an unexpected player in the immune reaction gone awry that causes vision loss in patients with age-related macular degeneration (AMD), according to a new study published today in eLife.

Potential way to halt blinding macular degeneration identified
It would be the first treatment for dry age-related macular degeneration and could significantly improve treatment for wet AMD.

Heating techniques could improve treatment of macular degeneration
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out.

Eye's vulnerability to macular degeneration revealed
Scientists have found significant differences in the shape and biology of the same type of cell taken from different parts of the retina, according to a study in eLife.

Hallucinations associated with brain hyperactivity in people with macular degeneration
New research from The University of Queensland has shown for the first time that visual hallucinations in people with macular degeneration are associated with abnormally heightened activity in the visual cortex of the brain.

Eating leafy greens could help prevent macular degeneration
A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD).

An orange a day keeps macular degeneration away: 15-year study
A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

Macular degeneration linked to aging immune cells
Studying mice and cells from patients, vision researchers at Washington University School of Medicine in St.

Read More: Macular Degeneration News and Macular Degeneration Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.